1 Sing, R, Barden, A, Mori, T, et al. (2001) Advanced glycation end products: a review. Diabetologia 44, 129–146.
2 Baynes, JW, Watkins, NG, Fisher, CI, et al. (1989) The Amadori product on protein: structure and reactions. Prog Clin Biol Res 304, 43–67.
3 Monnier, VM (1989) Structure elucidation of a senescence cross-link from human extracellular matrix. Implication of pentoses in the aging process. J Biol Chem 264, 21597–21602.
4 Vlassara, H (1996) Advanced glycation end products and atherosclerosis. Ann Med 28, 419–426.
5 Lyons, TJ, Silvestri, G, Dunn, JA, et al. (1991) Role of glycation in modification of lens crystallins in diabetic and nondiabetic senile cataracts. Diabetes 40, 1010–1015.
6 Brownlee, M (1995) Advanced protein glycosylation in diabetes and aging. Annu Rev Med 46, 223–234.
7 Shuvaev, VV, Laffont, I, Serot, JM, et al. (2001) Increased protein glycation in cerebrospinal fluid of Alzheimer's disease. Neurobiol Aging 22, 397–402.
8 Luthra, M & Balasubramanian, D (1993) Nonenzymatic glycation alters protein structure and stability. A study of two eye lens crystallins. J Biol Chem 268, 18119–18227.
9 Kumar, MS, Reddy, PY, Kumar, PA, et al. (2004) Effect of dicarbonyl-induced browning on α-crystallin chaperone-like activity: physiological significance and caveats of in vitro aggregation assays. Biochem J 379, 273–282.
10 Beswick, HT & Harding, JJ (1987) Conformational changes induced in lens α- and γ-crystallins by modification with glucose 6-phosphate. Implications for cataract. Biochem J 246, 761–769.
11 Stitt, A, Gardiner, TA, Alderson, NL, et al. (2002) The AGE inhibitor pyridoxamine inhibits development of retinopathy in experimental diabetes. Diabetes 51, 2826–2832.
12 Wada, R, Nishizawa, Y, Yagihashi, N, et al. (2001) Effects of OPB-9195, anti-glycation agent, on experimental diabetic neuropathy. Eur J Clin Invest 31, 513–520.
13 Vasan, S, Zhang, X, Zhang, X, et al. (1996) An agent cleaving glucose-derived protein crosslinks in vitro and in vivo. Nature 382, 275–278.
14 Edelstein, D & Brownlee, M (1992) Mechanistic studies of advanced glycosylation end product inhibition by aminoguanidine. Diabetes 41, 26–29.
15 Freedman, BI, Wuerth, JP, Cartwright, K, et al. (1999) Design and baseline characteristics for the aminoguanidine Clinical Trial in Overt Type 2 Diabetic Nephropathy (ACTION II). Control Clin Trials 20, 493–510.
16 Taguchi, T, Sugiura, M, Hamada, Y, et al. (1998) In vivo formation of a Schiff base of aminoguanidine with pyridoxal phosphate. Biochem Pharmacol 55, 1667–1671.
17 Ahmad, MS & Ahmed, N (2006) Antiglycation properties of aged garlic extract: possible role in prevention of diabetic complications. J Nutr 136, 796S–799S.
18 Grover, JK, Yadav, S & Vats, V (2002) Medicinal plants of India with antidiabetic potentials. J Ethnopharmacol 81, 81–100.
19 Saraswat, M, Reddy, PY, Muthenna, P, et al. (2009) Prevention of non-enzymic glycation of proteins by dietary agents: prospects for alleviating diabetic complications. Br J Nutr 101, 1714–1721.
20 Mrudula, T, Suryanarayana, P, Srinivas, PN, et al. (2007) Effect of curcumin on hyperglycemia-induced vascular endothelial growth factor expression in streptozotocin-induced diabetic rat retina. Biochem Biophys Res Commun 361, 528–532.
21 Kumar, PA, Reddy, PY, Srinivas, PN, et al. (2009) Delay of diabetic cataract in rats by the antiglycating potential of cumin through modulation of α-crystallin chaperone activity. J Nutr Biochem 20, 553–562.
22 Saraswat, M, Suryanarayana, P, Reddy, PY, et al. (2010) Antiglycating potential of Zingiber officinalis and delay of diabetic cataract in rats. Mol Vis 16, 1525–1537.
23 Kusirisin, W, Srichairatanakool, S, Lerttrakarnnon, P, et al. (2009) Antioxidative activity, polyphenolic content and anti-glycation effect of some Thai medicinal plants traditionally used in diabetic patients. Med Chem 5, 139–147.
24 Nakagawa, T, Yokozawa, T, Terasawa, K, et al. (2002) Protective activity of green tea against free radical- and glucose-mediated protein damage. J Agric Food Chem 50, 2418–2422.
25 Nagasawa, T, Tabata, N, Ito, Y, et al. (2003) Dietary G rutin suppresses glycation in tissue proteins of streptozotocin induced diabetic rats. Mol Cell Biochem 252, 141–147.
26 Pashikanti, S, de Alba, DR, Boissonneault, GA, et al. (2010) Rutin metabolites: novel inhibitors of nonoxidative advanced glycation end products. Free Radic Biol Med 48, 656–663.
27 Kumar, PA, Kumar, MS, Reddy, GB, et al. (2007) Effect of glycation on alpha-crystallin structure and chaperone-like function. Biochem J 408, 251–258.
28 Uchida, K, Kanematsu, M, Sakai, K, et al. (1998) Protein-bound acrolein: potential markers for oxidative stress. Proc Natl Acad Sci U S A 95, 4882–4887.
29 Price, DL, Rhett, PM, Thorpe, SR, et al. (2001) Chelating activity of advanced glycation end-product inhibitors. J Biol Chem 276, 48967–48972.
30 Brown, JE, Khodr, H, Hider, RC, et al. (1998) Structural dependence of flavonoid interactions with Cu2+ ions: implications for their antioxidant properties. Biochem J 330, 1173–1178.
31 Booth, AA, Khalifah, RG, Todd, P, et al. (1997) In vitro kinetic studies of formation of antigenic advanced glycation end products (AGEs): novel inhibition of post-Amadori glycation pathways. J Biol Chem 28, 5430–5437.
32 Suryanarayana, P, Saraswat, M, Mrudula, T, et al. (2005) Curcumin and turmeric delay streptozotocin-induced diabetic cataract in rats. Invest Ophthalmol Vis Sci 46, 2092–2099.
33 Padayatti, PS, Ng, AS, Uchida, K, et al. (2001) Argpyrimidine, a blue fluorophore in human lens proteins: high levels in brunescent cataractous lenses. Invest Ophthalmol Vis Sci 42, 1299–1304.
34 Ikeda, K, Higashi, T, Sano, H, et al. (1996) ɛ-(Carboxymethyl) lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction. Biochemistry 35, 8075–8083.
35 Nagaraj, RH, Shipanova, IN & Faust, FM (1996) Protein cross-linking by the Maillard reaction. Isolation, characterization, and in vivo detection of a lysine–lysine cross-link derived from methylglyoxal. J Biol Chem 271, 19338–19345.
36 Ahmed, MU, Brinkmann-Frye, E, Degenhardt, TP, et al. (1997) N-epsilon-(carboxyethyl)lysine, a product of the chemical modification of proteins by methylglyoxal, increases with age in human lens proteins. Biochem J 324, 565–570.
37 Glomb, MA & Monnier, VM (1995) Mechanism of protein modification by glyoxal and glycolaldehyde, reactive intermediates of the Maillard reaction. J Biol Chem 270, 10017–10026.
38 Saxena, P, Saxena, AK, Cui, XL, et al. (2000) Transition metal-catalyzed oxidation of ascorbate in human cataract extracts: possible role of advanced glycation end products. Invest Ophthalmol Vis Sci 41, 1473–1481.
39 Sajithlal, GB, Chithra, P & Chandrakasan, G (1998) The role of metal-catalyzed oxidation in the formation of advanced glycation end products: an in vitro study on collagen. Free Radic Biol Med 25, 265–269.
40 Mohan, V, Sandeep, S, Deepa, RB, et al. (2007) Epidemiology of type 2 diabetes: Indian scenario. Indian J Med Res 125, 217–230.
41 Wild, S, Roglic, G, Green, A, et al. (2004) Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 27, 1047–1053.
42 Nagasawa, T, Tabata, N, Ito, Y, et al. (2003) Inhibition of glycation reaction in tissue protein incubations by water soluble rutin derivative. Mol Cell Biochem 249, 3–10.
43 Cervantes-Laurean, D, Schramm, DD, Jacobson, EL, et al. (2006) Inhibition of advanced glycation end product formation on collagen by rutin and its metabolites. J Nutr Biochem 17, 531–540.
44 Griffiths, LA & Barrow, A (1972) Metabolism of flavonoid compounds in germ-free rats. Biochem J 130, 1161–1162.
45 Matsuda, H, Wang, T, Managi, H, et al. (2003) Structural requirements of flavonoids for inhibition of protein glycation and radical scavenging activities. Bioorg Med Chem 11, 5317–5323.